NCT05672225View on ClinicalTrials.gov

Two-channel IV-PCA With Dexmedetomidine

NARecruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

February 7, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2025

Conditions
Analgesia, Patient-ControlledDexmedetomidine
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine 0.2mcg/kg/hr (2ml/hr) administration via continuous channel in the experimental group

DRUG

Control

Normal saline 2ml/hr administration via continuous channel in the experimental group

Trial Locations (1)

Unknown

RECRUITING

Korea University Guro Hospital, Seoul

All Listed Sponsors
lead

Korea University Guro Hospital

OTHER